Literature DB >> 22090169

Metabolic restriction of cancer cells in vitro causes karyotype contraction--an indicator of cancer promotion?

Ying Li1, Paul Héroux, Igor Kyrychenko.   

Abstract

The metabolism of cultured cancer cells is stimulated by 21% oxygen and generous nutrition, while real tumors grow in oxygen and nutrient-restricted environments. The effect of these contrasted conditions was studied in five hyperploid (54-69) cancer cell lines. When grown under anoxia and in the presence of antioxidant metabolic restrictors, the cell lines quickly reverted to almost normal chromosome numbers (47-49). The stepped withdrawal of oxygen over K562 showed progressive increases in proliferation rate and the acquisition of a stable, stem phenotype. In genetic studies, hyperploid cancer cells adjusted their chromosome numbers up or down to match their micro-environment through rapid mechanisms of endo-reduplication or chromosome loss. These fast reactions may explain the surprising adaptability of tumor cells to oncologic interventions. Furthermore, karyotype contraction may provide a basis for the previously observed carcinogenic influence of the administration of some antioxidants in human populations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22090169     DOI: 10.1007/s13277-011-0262-6

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  74 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

2.  Endomitotic reduplication mechanisms in ascites tumors of the mouse.

Authors:  A LEVAN; T S HAUSCHKA
Journal:  J Natl Cancer Inst       Date:  1953-08       Impact factor: 13.506

3.  Induction of endoreduplication in cultured mammalian cells by some chemical mutagens.

Authors:  S Sutou; F Tokuyama
Journal:  Cancer Res       Date:  1974-10       Impact factor: 12.701

4.  Identification of highly elevated levels of melatonin in bone marrow: its origin and significance.

Authors:  D X Tan; L C Manchester; R J Reiter; W B Qi; M Zhang; S T Weintraub; J Cabrera; R M Sainz; J C Mayo
Journal:  Biochim Biophys Acta       Date:  1999-10-18

5.  AMP-activated protein kinase induces a p53-dependent metabolic checkpoint.

Authors:  Russell G Jones; David R Plas; Sara Kubek; Monica Buzzai; James Mu; Yang Xu; Morris J Birnbaum; Craig B Thompson
Journal:  Mol Cell       Date:  2005-04-29       Impact factor: 17.970

6.  Benzyl isothiocyanate inhibits oncogenic actions of leptin in human breast cancer cells by suppressing activation of signal transducer and activator of transcription 3.

Authors:  Su-Hyeong Kim; Arumugam Nagalingam; Neeraj K Saxena; Shivendra V Singh; Dipali Sharma
Journal:  Carcinogenesis       Date:  2010-12-16       Impact factor: 4.944

7.  MYC prevents apoptosis and enhances endoreduplication induced by paclitaxel.

Authors:  Giuliana Gatti; Giovanna Maresca; Manuela Natoli; Fulvio Florenzano; Angelo Nicolin; Armando Felsani; Igea D'Agnano
Journal:  PLoS One       Date:  2009-05-06       Impact factor: 3.240

Review 8.  Cancer stem cells, hypoxia and metastasis.

Authors:  Richard P Hill; Delphine T Marie-Egyptienne; David W Hedley
Journal:  Semin Radiat Oncol       Date:  2009-04       Impact factor: 5.934

9.  An improved technique for chromosomal analysis of human ES and iPS cells.

Authors:  Daniela Moralli; Mohammed Yusuf; Mohammad A Mandegar; Suhail Khoja; Zoia L Monaco; Emanuela V Volpi
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

10.  Mitochondrial oxidative stress drives tumor progression and metastasis: should we use antioxidants as a key component of cancer treatment and prevention?

Authors:  Federica Sotgia; Ubaldo E Martinez-Outschoorn; Michael P Lisanti
Journal:  BMC Med       Date:  2011-05-23       Impact factor: 8.775

View more
  1 in total

1.  Explore association of genes in PDL1/PD1 pathway to radiotherapy survival benefit based on interaction model strategy.

Authors:  Junjie Shen; Jingfang Liu; Peng Sun; Zaixiang Tang; Huijun Li; Lu Bai; Zixuan Du; Ruirui Geng; Jianping Cao
Journal:  Radiat Oncol       Date:  2021-11-18       Impact factor: 3.481

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.